The global BFS (blow-fill-seal) product market size was USD 374.4 Million in 2021 and is expected to register a revenue CAGR of 5.9% over the forecast period, according to the latest report by Reports and Data. New drug-ready technologies in various stages of development offer new options for pre-filled syringes, as they will be able to administer drugs with higher fill volumes and higher viscosities than subcutaneous injections.

To reduce staff involvement and risk of contamination when packaging liquid pharmaceuticals, more and more pharmaceutical manufacturers are using advanced sterilization techniques. It is preferred for pharmaceutical packaging because it offers advantages such as packaging versatility, low cost of ownership, significant sterility assurance, limited floor space, additional material inventories, and limited labor force. In addition, advances in BFS technology have enabled the packaging of a wider range of containers, including tipped and capped vials, resealable twist-top vials, multi-dose containers, eye wash and contact lens solution bottles. rice field. Injectable cans and beverage bottles for ionic liquids and prefilled syringes and devices for sporting events.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @

https://www.reportsanddata.com/download-free-sample/236

Some Key Highlights from the Report

• Based on product, the market is segmented into bottles, ampoules, vials, prefilled syringes, and others. The prefilled syringe segment accounted for a modest share of sales in 2021. Significant expansion of the prefilled syringe business and advances in syringe filling and finishing operations have been driven by the great need to develop vaccines and treatments for COVID-19 patients. Additionally, prefilled syringes minimize the number of steps required for injection, reducing the risk of injury and cross-contamination, and improving dosing accuracy. Prefilled syringes are now a widely accepted part of the drug lifecycle and are often considered during Phase II of the drug development process. In addition, the shift to home care and the desire for uniqueness continue to be major drivers of this transition. In addition, new drug-ready technologies in various stages of development offer new options for pre-filled syringes, as they will be able to administer drugs with higher fill volumes and higher viscosities than subcutaneous injections.
• On December 9, 2021, Woodstock Sterile Solutions, a renowned blow-fill-seal (BFS) contract developer and manufacturer (CDMO), received a US patent for cold BFS packaging and system technology. Throughout the BFS manufacturing process, this novel approach to advanced aseptic manufacturing helps reduce the effects of temperature on heat-sensitive molecules such as biologics. Within 15 seconds, the BFS process manufactures the container, fills it with product and seals it. All the while, it remains sterile and requires no human intervention. Plastic resin is melted throughout the process of making the container. The residual heat generated by this process makes the product susceptible to heat-related problems such as denaturation and precipitation. Some examples include allergens, proteins, monoclonal antibodies, blood or blood components, vaccines, biologics such as gene therapy.
• Companies profiled in the market report include Catalent, Inc., Recipharm AB, SALVAT, The Ritedose Corporation, BirgiMefar, Unicep, Pharmapacks, Unolab Manufacturing SL, Merck & Co., Inc., Weiler Engineering, Inc., Curida, and Horizon Therapeutics plc.
• For the purpose of this report, Reports and Data has segmented the global BFS (blow-fill-seal) product market based on Type Outlook, Product Outlook, Application Outlook, and Region:

Request Customization on this Report:

https://www.reportsanddata.com/request-customization-form/236

Type Outlook (Revenue, USD Billion; 2019-2030)

• High-Density Polyethylene
• Ethylene Vinyl Alcohol (EVOH)
• Polypropylene (PP)
• Low-Density Polyethylene (LDPE)

Product Outlook (Revenue, USD Billion; 2019-2030)

• Bottles
• Ampoules
• Vials
• Pre-Filled Syringes
• Others

Application Outlook (Revenue, USD Billion; 2019-2030)

• Food & Beverages
• Pharmaceuticals
• Cosmetic & Personal Care
• Others

Regional Outlook (Revenue, USD Billion; 2019-2030)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Sweden
  • BENELUX
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of MEA

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs